Simplify Logo

Full-Time

Lead – CMC Process Validation

Confirmed live in the last 24 hours

Orca Bio

Orca Bio

51-200 employees

Develops and commercializes cell therapies

Hardware
Biotechnology

Compensation Overview

$175k - $235kAnnually

Senior, Expert

Menlo Park, CA, USA

Category
Genomics
Biology Lab & Research
Biology & Biotech
Requirements
  • PhD in Pharmaceutical Sciences, Biology, Immunology, Cell Biology, with 12 years of relevant industry experience. Candidates with B.S./M.S. may also be considered with demonstrated leadership track record in process development and validation
  • History with commercialization projects and successful track record of BLA projects
  • Knowledge and broad understanding of validation principles associated with a GMP drug product manufacturing site. Good understanding of relevant ICH guidelines
  • Experience working with contract service providers and consultant contributors externally to complete project assignments
  • Experience in GMP cell therapy and/or biological product manufacturing, preferably with emphasis on cell therapy and individualized patient therapies
  • Experience working with and leading cross functional teams such as CMC, Quality and Regulatory
  • Outstanding written and verbal communication, self-starter with great interpersonal skills and strong planning/tracking skills
  • Must be able to work in a fast paced, changing environment with demonstrated ability to manage multiple competing responsibilities with a high degree of self-motivation
Responsibilities
  • Manage and develop strategic direction for all appropriate activities leading to process performance qualification (PPQ), associated CMC requirements and regulatory submissions
  • Manage and influence strategy for the development and monitoring of critical process controls and continued process verifications
  • Manages, tracks and reports on readiness/execution status for all proves validation activities and deliverables
  • Generates PPQ documents (plans, protocols, reports) according to timelines and commitments
  • Manage and mentor career development of cell therapy scientists; organize resourcing of projects and project assignments of group members
  • Author and review protocols, technical reports, method SOPs and/or work instructions. Responsible for all appropriate documentation for regulatory submissions
  • Develop and optimize validations for container closure, shipping systems and all appropriate validations needed for an IND and/or BLA submission for a cell therapy technology
  • Collaborate with and provide training and guidance to process validation and CMC group members in defining, executing and analyzing studies
  • Prepare and present high-quality data summaries and project progress updates to stakeholders and at cross-functional team meetings

Orca Bio operates in the biotechnology field, specifically focusing on cell therapies that utilize the body's own cells to treat diseases. The company aims to enhance these therapies to make them safer and more effective, ultimately improving patient outcomes. Orca Bio's products are designed for healthcare providers who administer these therapies to patients as part of their treatment plans. Unlike many competitors, Orca Bio emphasizes a strong team culture and values communication with stakeholders, keeping them informed about the company's progress and developments. The goal of Orca Bio is to significantly impact healthcare by advancing cell therapy treatments for conditions that currently have limited options.

Company Stage

Series D

Total Funding

$375M

Headquarters

Menlo Park, California

Founded

2016

Growth & Insights
Headcount

6 month growth

8%

1 year growth

14%

2 year growth

35%
Simplify Jobs

Simplify's Take

What believers are saying

  • Orca Bio's promising clinical data, including high relapse-free survival rates, highlight the potential for curative treatments in challenging patient groups.
  • The company's participation in prestigious conferences like the J.P. Morgan Healthcare Conference and the American Society of Hematology Annual Meeting underscores its industry recognition and thought leadership.
  • Orca Bio's strong team culture and commitment to employee value make it an attractive workplace for talented individuals in the biotechnology field.

What critics are saying

  • The competitive landscape in cell therapy and biotechnology requires continuous innovation to maintain a leading position.
  • Clinical trials and regulatory approvals are inherently risky and can lead to delays or failures, impacting the company's progress and financial stability.

What makes Orca Bio unique

  • Orca Bio's focus on high-precision cell therapies for cancer, autoimmune diseases, and genetic blood disorders sets it apart in the biotechnology sector.
  • Their proprietary single-cell precision manufacturing platform offers uniquely-defined products that aim to transform allogeneic cell therapy.
  • Orca Bio's investigational therapies, such as Orca-T and Orca-Q, demonstrate significantly better outcomes with fewer risks compared to standard treatments.